SCHEMBL1124496

SCHEMBL1124496

COc1ccc(C=CC(=O)O)nn1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NNMT P40261 1/20 0.49
THRB P10828 1/20 0.47
ATM Q13315 1/20 0.47
KDM4E B2RXH2 8/20 0.44
ALDH1A1 P00352 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
HPGD P15428 2/20 0.44
HSD17B10 Q99714 2/20 0.44
MAPK1 P28482 2/20 0.44
LMNA P02545 1/20 0.44
ALOX15 P16050 1/20 0.44
PKM P14618 3/20 0.41
CA12 O43570 2/20 0.41
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
CA3 P07451 2/20 0.41
CA4 P22748 2/20 0.41
CA6 P23280 2/20 0.41
CA5A P35218 2/20 0.41
CA7 P43166 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1124495 1.00 NNMT (0.49) NNMTTHRBATMKDM4EALDH1A1
SCHEMBL20153867 0.79 FDPS (0.49) NNMTALDH1A1LMNACA12CA1
SCHEMBL1225315 0.76 KDM4E (0.49) THRBATMKDM4EALDH1A1SMN1; SMN2
SCHEMBL1225317 0.76 KDM4E (0.49) THRBATMKDM4EALDH1A1SMN1; SMN2
SCHEMBL13505664 0.74 KDM4E (0.46) THRBATMKDM4EALDH1A1HPGD
SCHEMBL13505667 0.74 KDM4E (0.46) THRBATMKDM4EALDH1A1HPGD
SCHEMBL4322108 0.74 NNMT (0.56) NNMTKDM4EALDH1A1SMN1; SMN2LMNA
SCHEMBL1124202 0.74 THRB (0.59) THRBATMKDM4EALDH1A1SMN1; SMN2
SCHEMBL1124205 0.74 THRB (0.59) THRBATMKDM4EALDH1A1SMN1; SMN2
SCHEMBL15633727 0.72 NNMT (0.44) NNMTKDM4EALDH1A1SMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110281869-A1 TETRAHYDROISOQUINOLINES AS ANTIMALARIAL AGENTS AISSAOUI HAMED (FR) 2011-11-17 US disclosed
EP-2282996-A1 TETRAHYDROISOQUINOLINES AS ANTIMALARIAL AGENTS Actelion Pharmaceuticals Ltd. (CH) 2011-02-16 EP disclosed
WO-2009141782-A1 TETRAHYDROISOQUINOLINES AS ANTIMALARIAL AGENTS ACTELION PHARMACEUTICALS LTD (CH) 2009-11-26 WO disclosed
US-5670492-A BACTERICIDE, ANTITUMOR AGENT KYOWA HAKKO KOGYO CO., LTD. (JP) 1997-09-23 US disclosed
EP-0702014-A1 DC-89 DERIVATIVE KYOWA HAKKO KOGYO CO., LTD. (JP) 1996-03-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110281869-A1 TETRAHYDROISOQUINOLINES AS ANTIMALARIAL AGENTS QTRT2, RECQL, QTRT1 NNMT 375/4885THRB 4697/4885ATM 4487/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.